TP53 and gastric cancer: This study demonstrates that metformin treatment significantly increases the sensitively of cisplatin in gastric cancer cells, the increasing appears to be largely dependent to the inhibition of Nrf2 expression and metabolic reprogramming and the activation of oxidative stress and the pathway of p53 and AMPK.